The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial
Eight-week supplementation with 1.5 g/day chitosan along with a low-calorie diet could possibly reduce weight, waist circumference, AST, ALT, and GGT, and ameliorate NAFLD. Further investigations are recommended. Trial registration The trial was registered at IRCT.ir as IRCT20140502017522N4 (March 2023).
Authors
- Maryam Taghdir (ORCID: https://orcid.org/0000-0003-2853-0196)
- Mohammad Amin Jafari (ORCID: https://orcid.org/0000-0003-0617-2412)
- R. A. Borzooei (ORCID: https://orcid.org/0000-0001-7538-7885)
- Sepideh Abbaszadeh (ORCID: https://orcid.org/0000-0003-2280-8687)
- Marzieh Akbarzadeh (ORCID: https://orcid.org/0000-0001-7646-2162)
- Karim Parastouei
- M H Rad (ORCID: https://orcid.org/0009-0003-8341-8153)
- Mohammad Ali Mohsenpoor
- Mohammad Ali Abyazi Heris
Institutions
- Baqiyatallah University of Medical Sciences (IR)
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Health Population and Nutrition
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1186/s41043-025-00797-3
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35